We conduct both clinical and translational research.
In the translational setting we study genetic changes in melanoma and kidney cancers and their interaction with the cancer environment, in particular the immune system.
We are interested in how particular genetic changes and the order in which they happen impacts cancer progression, metastasis and treatment. We are tracking these changes in the blood to find out if they reflect what is happening at the level of the tumour.
Ultimately we want to translate these observations into clinical applications that help us manage our patients.